nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—CYP2C9—brain cancer	0.722	1	CbGaD
Etodolac—PTGS2—Etoposide—brain cancer	0.0174	0.542	CbGbCtD
Etodolac—PTGS1—Etoposide—brain cancer	0.0147	0.458	CbGbCtD
Etodolac—UGT1A10—Tamoxifen metabolism—CYP2C9—brain cancer	0.00622	0.125	CbGpPWpGaD
Etodolac—RXRA—ganglion—brain cancer	0.00404	0.183	CbGeAlD
Etodolac—UGT1A10—Irinotecan Pathway—APC—brain cancer	0.00228	0.0457	CbGpPWpGaD
Etodolac—UGT2B7—Tamoxifen metabolism—CYP2C9—brain cancer	0.00211	0.0422	CbGpPWpGaD
Etodolac—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00183	0.0366	CbGpPWpGaD
Etodolac—UGT1A3—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00177	0.0354	CbGpPWpGaD
Etodolac—UGT1A10—endocrine gland—brain cancer	0.00165	0.0746	CbGeAlD
Etodolac—RXRA—telencephalon—brain cancer	0.00156	0.0705	CbGeAlD
Etodolac—RXRA—Pyruvate metabolism—BSG—brain cancer	0.0015	0.0301	CbGpPWpGaD
Etodolac—PTGS2—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00145	0.029	CbGpPWpGaD
Etodolac—RXRA—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0014	0.0281	CbGpPWpGaD
Etodolac—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00127	0.0254	CbGpPWpGaD
Etodolac—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00122	0.0245	CbGpPWpGaD
Etodolac—UGT1A3—endocrine gland—brain cancer	0.00116	0.0525	CbGeAlD
Etodolac—UGT1A10—Metapathway biotransformation—CYP2C9—brain cancer	0.00114	0.0229	CbGpPWpGaD
Etodolac—PTGS2—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.001	0.0201	CbGpPWpGaD
Etodolac—RXRA—endocrine gland—brain cancer	0.000984	0.0445	CbGeAlD
Etodolac—RXRA—head—brain cancer	0.000971	0.0439	CbGeAlD
Etodolac—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.000908	0.0182	CbGpPWpGaD
Etodolac—PTGS1—ganglion—brain cancer	0.000895	0.0405	CbGeAlD
Etodolac—RXRA—central nervous system—brain cancer	0.000886	0.0401	CbGeAlD
Etodolac—RXRA—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000848	0.017	CbGpPWpGaD
Etodolac—UGT1A9—endocrine gland—brain cancer	0.000828	0.0374	CbGeAlD
Etodolac—PTGS1—endothelium—brain cancer	0.000771	0.0349	CbGeAlD
Etodolac—PTGS2—endothelium—brain cancer	0.000737	0.0333	CbGeAlD
Etodolac—PTGS1—blood vessel—brain cancer	0.000711	0.0322	CbGeAlD
Etodolac—RXRA—brain—brain cancer	0.000704	0.0318	CbGeAlD
Etodolac—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000697	0.014	CbGpPWpGaD
Etodolac—RXRA—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000687	0.0138	CbGpPWpGaD
Etodolac—PTGS2—blood vessel—brain cancer	0.00068	0.0308	CbGeAlD
Etodolac—UGT2B7—endocrine gland—brain cancer	0.000667	0.0302	CbGeAlD
Etodolac—RXRA—Orphan transporters—S100A10—brain cancer	0.000659	0.0132	CbGpPWpGaD
Etodolac—RXRA—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000639	0.0128	CbGpPWpGaD
Etodolac—UGT1A9—Irinotecan Pathway—APC—brain cancer	0.000627	0.0126	CbGpPWpGaD
Etodolac—RXRA—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.000568	0.0114	CbGpPWpGaD
Etodolac—RXRA—Nuclear Receptors—ESR2—brain cancer	0.000565	0.0113	CbGpPWpGaD
Etodolac—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000553	0.0111	CbGpPWpGaD
Etodolac—Hallucination—Hydroxyurea—brain cancer	0.000539	0.0031	CcSEcCtD
Etodolac—Loss of consciousness—Procarbazine—brain cancer	0.000536	0.00308	CcSEcCtD
Etodolac—Abdominal distension—Temozolomide—brain cancer	0.000532	0.00306	CcSEcCtD
Etodolac—Convulsion—Procarbazine—brain cancer	0.000528	0.00304	CcSEcCtD
Etodolac—Hypertension—Procarbazine—brain cancer	0.000526	0.00303	CcSEcCtD
Etodolac—Pancytopenia—Carmustine—brain cancer	0.00052	0.00299	CcSEcCtD
Etodolac—Arthralgia—Procarbazine—brain cancer	0.000519	0.00298	CcSEcCtD
Etodolac—Myalgia—Procarbazine—brain cancer	0.000519	0.00298	CcSEcCtD
Etodolac—Anxiety—Procarbazine—brain cancer	0.000517	0.00297	CcSEcCtD
Etodolac—Neutropenia—Carmustine—brain cancer	0.000512	0.00294	CcSEcCtD
Etodolac—Bronchitis—Temozolomide—brain cancer	0.000509	0.00292	CcSEcCtD
Etodolac—Dry mouth—Procarbazine—brain cancer	0.000507	0.00292	CcSEcCtD
Etodolac—Anaphylactoid reaction—Etoposide—brain cancer	0.000506	0.00291	CcSEcCtD
Etodolac—Pancytopenia—Temozolomide—brain cancer	0.000502	0.00289	CcSEcCtD
Etodolac—Confusional state—Procarbazine—brain cancer	0.000501	0.00288	CcSEcCtD
Etodolac—Vomiting—Lomustine—brain cancer	0.000498	0.00286	CcSEcCtD
Etodolac—Oedema—Procarbazine—brain cancer	0.000497	0.00286	CcSEcCtD
Etodolac—Dysuria—Temozolomide—brain cancer	0.000494	0.00284	CcSEcCtD
Etodolac—Neutropenia—Temozolomide—brain cancer	0.000494	0.00284	CcSEcCtD
Etodolac—Infection—Procarbazine—brain cancer	0.000494	0.00284	CcSEcCtD
Etodolac—Hyperglycaemia—Carmustine—brain cancer	0.000494	0.00284	CcSEcCtD
Etodolac—Pneumonia—Carmustine—brain cancer	0.000491	0.00282	CcSEcCtD
Etodolac—Shock—Procarbazine—brain cancer	0.000489	0.00281	CcSEcCtD
Etodolac—Pollakiuria—Temozolomide—brain cancer	0.000488	0.00281	CcSEcCtD
Etodolac—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000488	0.00979	CbGpPWpGaD
Etodolac—Thrombocytopenia—Procarbazine—brain cancer	0.000487	0.0028	CcSEcCtD
Etodolac—Chills—Hydroxyurea—brain cancer	0.000486	0.0028	CcSEcCtD
Etodolac—Tachycardia—Procarbazine—brain cancer	0.000485	0.00279	CcSEcCtD
Etodolac—Photosensitivity reaction—Temozolomide—brain cancer	0.000483	0.00278	CcSEcCtD
Etodolac—Hyperhidrosis—Procarbazine—brain cancer	0.000481	0.00276	CcSEcCtD
Etodolac—Renal failure—Carmustine—brain cancer	0.00048	0.00276	CcSEcCtD
Etodolac—Alopecia—Hydroxyurea—brain cancer	0.000479	0.00275	CcSEcCtD
Etodolac—Hyperglycaemia—Temozolomide—brain cancer	0.000477	0.00274	CcSEcCtD
Etodolac—Stomatitis—Carmustine—brain cancer	0.000476	0.00273	CcSEcCtD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000475	0.00952	CbGpPWpGaD
Etodolac—Pneumonia—Temozolomide—brain cancer	0.000474	0.00273	CcSEcCtD
Etodolac—Anorexia—Procarbazine—brain cancer	0.000474	0.00273	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000467	0.00269	CcSEcCtD
Etodolac—RXRA—PPAR Alpha Pathway—CDK4—brain cancer	0.000466	0.00935	CbGpPWpGaD
Etodolac—Nausea—Lomustine—brain cancer	0.000465	0.00268	CcSEcCtD
Etodolac—Hypotension—Procarbazine—brain cancer	0.000465	0.00267	CcSEcCtD
Etodolac—UGT1A3—Biological oxidations—CYP2C9—brain cancer	0.00046	0.00923	CbGpPWpGaD
Etodolac—Stomatitis—Temozolomide—brain cancer	0.00046	0.00264	CcSEcCtD
Etodolac—UGT1A3—Metapathway biotransformation—CYP2C9—brain cancer	0.000454	0.0091	CbGpPWpGaD
Etodolac—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000453	0.00261	CcSEcCtD
Etodolac—Insomnia—Procarbazine—brain cancer	0.00045	0.00259	CcSEcCtD
Etodolac—RXRA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000447	0.00895	CbGpPWpGaD
Etodolac—Paraesthesia—Procarbazine—brain cancer	0.000447	0.00257	CcSEcCtD
Etodolac—Sinusitis—Temozolomide—brain cancer	0.000442	0.00254	CcSEcCtD
Etodolac—Somnolence—Procarbazine—brain cancer	0.000442	0.00254	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000441	0.00254	CcSEcCtD
Etodolac—Haemoglobin—Carmustine—brain cancer	0.00044	0.00253	CcSEcCtD
Etodolac—SLC22A6—brain—brain cancer	0.000438	0.0198	CbGeAlD
Etodolac—Haemorrhage—Carmustine—brain cancer	0.000438	0.00252	CcSEcCtD
Etodolac—Ill-defined disorder—Hydroxyurea—brain cancer	0.000438	0.00252	CcSEcCtD
Etodolac—Anaemia—Hydroxyurea—brain cancer	0.000436	0.00251	CcSEcCtD
Etodolac—Hallucination—Carmustine—brain cancer	0.000436	0.00251	CcSEcCtD
Etodolac—Decreased appetite—Procarbazine—brain cancer	0.000432	0.00249	CcSEcCtD
Etodolac—Fatigue—Procarbazine—brain cancer	0.000429	0.00247	CcSEcCtD
Etodolac—Haemoglobin—Temozolomide—brain cancer	0.000425	0.00245	CcSEcCtD
Etodolac—Malaise—Hydroxyurea—brain cancer	0.000425	0.00245	CcSEcCtD
Etodolac—Constipation—Procarbazine—brain cancer	0.000425	0.00245	CcSEcCtD
Etodolac—Pain—Procarbazine—brain cancer	0.000425	0.00245	CcSEcCtD
Etodolac—Hepatitis—Temozolomide—brain cancer	0.000423	0.00243	CcSEcCtD
Etodolac—Haemorrhage—Temozolomide—brain cancer	0.000423	0.00243	CcSEcCtD
Etodolac—Leukopenia—Hydroxyurea—brain cancer	0.000422	0.00243	CcSEcCtD
Etodolac—Visual impairment—Carmustine—brain cancer	0.000422	0.00243	CcSEcCtD
Etodolac—Hallucination—Temozolomide—brain cancer	0.000421	0.00242	CcSEcCtD
Etodolac—Pharyngitis—Temozolomide—brain cancer	0.00042	0.00242	CcSEcCtD
Etodolac—Bronchospasm—Etoposide—brain cancer	0.000416	0.00239	CcSEcCtD
Etodolac—Feeling abnormal—Procarbazine—brain cancer	0.00041	0.00236	CcSEcCtD
Etodolac—Convulsion—Hydroxyurea—brain cancer	0.000409	0.00235	CcSEcCtD
Etodolac—Visual impairment—Temozolomide—brain cancer	0.000408	0.00235	CcSEcCtD
Etodolac—Gastrointestinal pain—Procarbazine—brain cancer	0.000407	0.00234	CcSEcCtD
Etodolac—Flushing—Carmustine—brain cancer	0.000406	0.00234	CcSEcCtD
Etodolac—UGT1A9—PPAR Alpha Pathway—CDK4—brain cancer	0.000406	0.00814	CbGpPWpGaD
Etodolac—Pancytopenia—Etoposide—brain cancer	0.000402	0.00231	CcSEcCtD
Etodolac—Erythema multiforme—Temozolomide—brain cancer	0.0004	0.0023	CcSEcCtD
Etodolac—Discomfort—Hydroxyurea—brain cancer	0.000397	0.00228	CcSEcCtD
Etodolac—Neutropenia—Etoposide—brain cancer	0.000396	0.00228	CcSEcCtD
Etodolac—Urticaria—Procarbazine—brain cancer	0.000395	0.00227	CcSEcCtD
Etodolac—Tinnitus—Temozolomide—brain cancer	0.000395	0.00227	CcSEcCtD
Etodolac—Body temperature increased—Procarbazine—brain cancer	0.000393	0.00226	CcSEcCtD
Etodolac—Abdominal pain—Procarbazine—brain cancer	0.000393	0.00226	CcSEcCtD
Etodolac—Flushing—Temozolomide—brain cancer	0.000393	0.00226	CcSEcCtD
Etodolac—UGT2B7—Biological oxidations—CYP2C9—brain cancer	0.000391	0.00785	CbGpPWpGaD
Etodolac—Arrhythmia—Carmustine—brain cancer	0.000391	0.00225	CcSEcCtD
Etodolac—Alopecia—Carmustine—brain cancer	0.000387	0.00223	CcSEcCtD
Etodolac—UGT2B7—Metapathway biotransformation—CYP2C9—brain cancer	0.000386	0.00774	CbGpPWpGaD
Etodolac—Oedema—Hydroxyurea—brain cancer	0.000385	0.00221	CcSEcCtD
Etodolac—Infection—Hydroxyurea—brain cancer	0.000382	0.0022	CcSEcCtD
Etodolac—Chills—Temozolomide—brain cancer	0.00038	0.00218	CcSEcCtD
Etodolac—Pneumonia—Etoposide—brain cancer	0.000379	0.00218	CcSEcCtD
Etodolac—Thrombocytopenia—Hydroxyurea—brain cancer	0.000377	0.00217	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000374	0.00215	CcSEcCtD
Etodolac—Alopecia—Temozolomide—brain cancer	0.000374	0.00215	CcSEcCtD
Etodolac—Acute coronary syndrome—Etoposide—brain cancer	0.000372	0.00214	CcSEcCtD
Etodolac—Renal failure—Etoposide—brain cancer	0.000371	0.00213	CcSEcCtD
Etodolac—Myocardial infarction—Etoposide—brain cancer	0.00037	0.00213	CcSEcCtD
Etodolac—Jaundice—Etoposide—brain cancer	0.000368	0.00211	CcSEcCtD
Etodolac—Stomatitis—Etoposide—brain cancer	0.000368	0.00211	CcSEcCtD
Etodolac—Anorexia—Hydroxyurea—brain cancer	0.000367	0.00211	CcSEcCtD
Etodolac—Hypersensitivity—Procarbazine—brain cancer	0.000366	0.00211	CcSEcCtD
Etodolac—RXRA—Biological oxidations—CYP2C9—brain cancer	0.000365	0.00732	CbGpPWpGaD
Etodolac—Dysgeusia—Temozolomide—brain cancer	0.000361	0.00207	CcSEcCtD
Etodolac—Vision blurred—Carmustine—brain cancer	0.000359	0.00207	CcSEcCtD
Etodolac—Tremor—Carmustine—brain cancer	0.000357	0.00205	CcSEcCtD
Etodolac—Asthenia—Procarbazine—brain cancer	0.000357	0.00205	CcSEcCtD
Etodolac—Anaemia—Carmustine—brain cancer	0.000352	0.00203	CcSEcCtD
Etodolac—Agranulocytosis—Etoposide—brain cancer	0.000352	0.00202	CcSEcCtD
Etodolac—RXRA—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.000352	0.00706	CbGpPWpGaD
Etodolac—Pruritus—Procarbazine—brain cancer	0.000352	0.00202	CcSEcCtD
Etodolac—RXRA—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000349	0.00699	CbGpPWpGaD
Etodolac—Vision blurred—Temozolomide—brain cancer	0.000347	0.002	CcSEcCtD
Etodolac—Tremor—Temozolomide—brain cancer	0.000345	0.00199	CcSEcCtD
Etodolac—PTGS1—telencephalon—brain cancer	0.000345	0.0156	CbGeAlD
Etodolac—Dyspnoea—Hydroxyurea—brain cancer	0.000343	0.00197	CcSEcCtD
Etodolac—Somnolence—Hydroxyurea—brain cancer	0.000342	0.00197	CcSEcCtD
Etodolac—Ill-defined disorder—Temozolomide—brain cancer	0.000342	0.00197	CcSEcCtD
Etodolac—Leukopenia—Carmustine—brain cancer	0.000341	0.00196	CcSEcCtD
Etodolac—Anaemia—Temozolomide—brain cancer	0.000341	0.00196	CcSEcCtD
Etodolac—Diarrhoea—Procarbazine—brain cancer	0.00034	0.00196	CcSEcCtD
Etodolac—Dyspepsia—Hydroxyurea—brain cancer	0.000339	0.00195	CcSEcCtD
Etodolac—Angioedema—Temozolomide—brain cancer	0.000337	0.00194	CcSEcCtD
Etodolac—Decreased appetite—Hydroxyurea—brain cancer	0.000335	0.00192	CcSEcCtD
Etodolac—Malaise—Temozolomide—brain cancer	0.000332	0.00191	CcSEcCtD
Etodolac—Fatigue—Hydroxyurea—brain cancer	0.000332	0.00191	CcSEcCtD
Etodolac—Vertigo—Temozolomide—brain cancer	0.000331	0.0019	CcSEcCtD
Etodolac—Convulsion—Carmustine—brain cancer	0.00033	0.0019	CcSEcCtD
Etodolac—PTGS2—telencephalon—brain cancer	0.00033	0.0149	CbGeAlD
Etodolac—Leukopenia—Temozolomide—brain cancer	0.00033	0.0019	CcSEcCtD
Etodolac—Hypertension—Carmustine—brain cancer	0.000329	0.00189	CcSEcCtD
Etodolac—Constipation—Hydroxyurea—brain cancer	0.000329	0.00189	CcSEcCtD
Etodolac—Pain—Hydroxyurea—brain cancer	0.000329	0.00189	CcSEcCtD
Etodolac—Dizziness—Procarbazine—brain cancer	0.000329	0.00189	CcSEcCtD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000328	0.00658	CbGpPWpGaD
Etodolac—Palpitations—Temozolomide—brain cancer	0.000326	0.00187	CcSEcCtD
Etodolac—Myalgia—Carmustine—brain cancer	0.000325	0.00187	CcSEcCtD
Etodolac—Anxiety—Carmustine—brain cancer	0.000323	0.00186	CcSEcCtD
Etodolac—Erythema multiforme—Etoposide—brain cancer	0.00032	0.00184	CcSEcCtD
Etodolac—Convulsion—Temozolomide—brain cancer	0.000319	0.00184	CcSEcCtD
Etodolac—UGT1A9—Biological oxidations—CYP2C9—brain cancer	0.000318	0.00638	CbGpPWpGaD
Etodolac—Hypertension—Temozolomide—brain cancer	0.000318	0.00183	CcSEcCtD
Etodolac—Feeling abnormal—Hydroxyurea—brain cancer	0.000317	0.00182	CcSEcCtD
Etodolac—Vomiting—Procarbazine—brain cancer	0.000316	0.00182	CcSEcCtD
Etodolac—Flushing—Etoposide—brain cancer	0.000314	0.00181	CcSEcCtD
Etodolac—UGT1A9—Metapathway biotransformation—CYP2C9—brain cancer	0.000314	0.00629	CbGpPWpGaD
Etodolac—Confusional state—Carmustine—brain cancer	0.000314	0.0018	CcSEcCtD
Etodolac—Myalgia—Temozolomide—brain cancer	0.000314	0.0018	CcSEcCtD
Etodolac—Arthralgia—Temozolomide—brain cancer	0.000314	0.0018	CcSEcCtD
Etodolac—Rash—Procarbazine—brain cancer	0.000314	0.0018	CcSEcCtD
Etodolac—Dermatitis—Procarbazine—brain cancer	0.000313	0.0018	CcSEcCtD
Etodolac—Anxiety—Temozolomide—brain cancer	0.000313	0.0018	CcSEcCtD
Etodolac—Headache—Procarbazine—brain cancer	0.000312	0.00179	CcSEcCtD
Etodolac—Oedema—Carmustine—brain cancer	0.000311	0.00179	CcSEcCtD
Etodolac—Discomfort—Temozolomide—brain cancer	0.00031	0.00178	CcSEcCtD
Etodolac—Infection—Carmustine—brain cancer	0.000309	0.00178	CcSEcCtD
Etodolac—Dry mouth—Temozolomide—brain cancer	0.000307	0.00176	CcSEcCtD
Etodolac—Thrombocytopenia—Carmustine—brain cancer	0.000305	0.00175	CcSEcCtD
Etodolac—Body temperature increased—Hydroxyurea—brain cancer	0.000304	0.00175	CcSEcCtD
Etodolac—Chills—Etoposide—brain cancer	0.000304	0.00175	CcSEcCtD
Etodolac—Tachycardia—Carmustine—brain cancer	0.000304	0.00175	CcSEcCtD
Etodolac—Confusional state—Temozolomide—brain cancer	0.000303	0.00174	CcSEcCtD
Etodolac—RXRA—PPAR Alpha Pathway—CCND1—brain cancer	0.000301	0.00604	CbGpPWpGaD
Etodolac—Oedema—Temozolomide—brain cancer	0.000301	0.00173	CcSEcCtD
Etodolac—Anaphylactic shock—Temozolomide—brain cancer	0.000301	0.00173	CcSEcCtD
Etodolac—Alopecia—Etoposide—brain cancer	0.000299	0.00172	CcSEcCtD
Etodolac—Infection—Temozolomide—brain cancer	0.000299	0.00172	CcSEcCtD
Etodolac—Anorexia—Carmustine—brain cancer	0.000297	0.00171	CcSEcCtD
Etodolac—Nausea—Procarbazine—brain cancer	0.000295	0.0017	CcSEcCtD
Etodolac—Thrombocytopenia—Temozolomide—brain cancer	0.000294	0.00169	CcSEcCtD
Etodolac—Hypotension—Carmustine—brain cancer	0.000291	0.00167	CcSEcCtD
Etodolac—Hyperhidrosis—Temozolomide—brain cancer	0.000291	0.00167	CcSEcCtD
Etodolac—Dysgeusia—Etoposide—brain cancer	0.000289	0.00166	CcSEcCtD
Etodolac—Anorexia—Temozolomide—brain cancer	0.000287	0.00165	CcSEcCtD
Etodolac—Hypersensitivity—Hydroxyurea—brain cancer	0.000284	0.00163	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Carmustine—brain cancer	0.000283	0.00163	CcSEcCtD
Etodolac—Insomnia—Carmustine—brain cancer	0.000281	0.00162	CcSEcCtD
Etodolac—PTGS1—pituitary gland—brain cancer	0.000281	0.0127	CbGeAlD
Etodolac—Paraesthesia—Carmustine—brain cancer	0.000279	0.00161	CcSEcCtD
Etodolac—Dyspnoea—Carmustine—brain cancer	0.000277	0.0016	CcSEcCtD
Etodolac—Somnolence—Carmustine—brain cancer	0.000277	0.00159	CcSEcCtD
Etodolac—Asthenia—Hydroxyurea—brain cancer	0.000276	0.00159	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000274	0.00158	CcSEcCtD
Etodolac—Ill-defined disorder—Etoposide—brain cancer	0.000274	0.00157	CcSEcCtD
Etodolac—ALB—brain—brain cancer	0.000273	0.0124	CbGeAlD
Etodolac—Anaemia—Etoposide—brain cancer	0.000272	0.00157	CcSEcCtD
Etodolac—Insomnia—Temozolomide—brain cancer	0.000272	0.00156	CcSEcCtD
Etodolac—Decreased appetite—Carmustine—brain cancer	0.00027	0.00156	CcSEcCtD
Etodolac—Paraesthesia—Temozolomide—brain cancer	0.00027	0.00155	CcSEcCtD
Etodolac—PTGS2—pituitary gland—brain cancer	0.000269	0.0121	CbGeAlD
Etodolac—Dyspnoea—Temozolomide—brain cancer	0.000268	0.00154	CcSEcCtD
Etodolac—Somnolence—Temozolomide—brain cancer	0.000267	0.00154	CcSEcCtD
Etodolac—Pain—Carmustine—brain cancer	0.000266	0.00153	CcSEcCtD
Etodolac—Constipation—Carmustine—brain cancer	0.000266	0.00153	CcSEcCtD
Etodolac—Malaise—Etoposide—brain cancer	0.000266	0.00153	CcSEcCtD
Etodolac—Vertigo—Etoposide—brain cancer	0.000265	0.00152	CcSEcCtD
Etodolac—Dyspepsia—Temozolomide—brain cancer	0.000265	0.00152	CcSEcCtD
Etodolac—Leukopenia—Etoposide—brain cancer	0.000264	0.00152	CcSEcCtD
Etodolac—Diarrhoea—Hydroxyurea—brain cancer	0.000263	0.00151	CcSEcCtD
Etodolac—UGT1A9—PPAR Alpha Pathway—CCND1—brain cancer	0.000262	0.00526	CbGpPWpGaD
Etodolac—Decreased appetite—Temozolomide—brain cancer	0.000261	0.0015	CcSEcCtD
Etodolac—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000259	0.0052	CbGpPWpGaD
Etodolac—Fatigue—Temozolomide—brain cancer	0.000259	0.00149	CcSEcCtD
Etodolac—PTGS2—medulla oblongata—brain cancer	0.000259	0.0117	CbGeAlD
Etodolac—Loss of consciousness—Etoposide—brain cancer	0.000259	0.00149	CcSEcCtD
Etodolac—Constipation—Temozolomide—brain cancer	0.000257	0.00148	CcSEcCtD
Etodolac—Pain—Temozolomide—brain cancer	0.000257	0.00148	CcSEcCtD
Etodolac—Feeling abnormal—Carmustine—brain cancer	0.000256	0.00147	CcSEcCtD
Etodolac—Convulsion—Etoposide—brain cancer	0.000255	0.00147	CcSEcCtD
Etodolac—Hypertension—Etoposide—brain cancer	0.000255	0.00146	CcSEcCtD
Etodolac—Dizziness—Hydroxyurea—brain cancer	0.000255	0.00146	CcSEcCtD
Etodolac—Gastrointestinal pain—Carmustine—brain cancer	0.000254	0.00146	CcSEcCtD
Etodolac—Discomfort—Etoposide—brain cancer	0.000248	0.00143	CcSEcCtD
Etodolac—Feeling abnormal—Temozolomide—brain cancer	0.000248	0.00142	CcSEcCtD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000247	0.00495	CbGpPWpGaD
Etodolac—Abdominal pain—Carmustine—brain cancer	0.000246	0.00141	CcSEcCtD
Etodolac—Body temperature increased—Carmustine—brain cancer	0.000246	0.00141	CcSEcCtD
Etodolac—Gastrointestinal pain—Temozolomide—brain cancer	0.000246	0.00141	CcSEcCtD
Etodolac—Vomiting—Hydroxyurea—brain cancer	0.000245	0.00141	CcSEcCtD
Etodolac—Rash—Hydroxyurea—brain cancer	0.000243	0.0014	CcSEcCtD
Etodolac—Confusional state—Etoposide—brain cancer	0.000243	0.0014	CcSEcCtD
Etodolac—Dermatitis—Hydroxyurea—brain cancer	0.000242	0.00139	CcSEcCtD
Etodolac—PTGS1—spinal cord—brain cancer	0.000242	0.0109	CbGeAlD
Etodolac—RXRA—PPAR Alpha Pathway—MYC—brain cancer	0.000242	0.00484	CbGpPWpGaD
Etodolac—Headache—Hydroxyurea—brain cancer	0.000241	0.00139	CcSEcCtD
Etodolac—Anaphylactic shock—Etoposide—brain cancer	0.000241	0.00138	CcSEcCtD
Etodolac—Infection—Etoposide—brain cancer	0.000239	0.00137	CcSEcCtD
Etodolac—Urticaria—Temozolomide—brain cancer	0.000239	0.00137	CcSEcCtD
Etodolac—CYP2C9—endocrine gland—brain cancer	0.000238	0.0108	CbGeAlD
Etodolac—Abdominal pain—Temozolomide—brain cancer	0.000238	0.00137	CcSEcCtD
Etodolac—Body temperature increased—Temozolomide—brain cancer	0.000238	0.00137	CcSEcCtD
Etodolac—PTGS2—midbrain—brain cancer	0.000237	0.0107	CbGeAlD
Etodolac—Thrombocytopenia—Etoposide—brain cancer	0.000236	0.00135	CcSEcCtD
Etodolac—Tachycardia—Etoposide—brain cancer	0.000235	0.00135	CcSEcCtD
Etodolac—Hyperhidrosis—Etoposide—brain cancer	0.000233	0.00134	CcSEcCtD
Etodolac—PTGS2—spinal cord—brain cancer	0.000231	0.0105	CbGeAlD
Etodolac—Anorexia—Etoposide—brain cancer	0.000229	0.00132	CcSEcCtD
Etodolac—Hypersensitivity—Carmustine—brain cancer	0.000229	0.00132	CcSEcCtD
Etodolac—Nausea—Hydroxyurea—brain cancer	0.000229	0.00131	CcSEcCtD
Etodolac—Hypotension—Etoposide—brain cancer	0.000225	0.00129	CcSEcCtD
Etodolac—Asthenia—Carmustine—brain cancer	0.000223	0.00128	CcSEcCtD
Etodolac—Hypersensitivity—Temozolomide—brain cancer	0.000222	0.00127	CcSEcCtD
Etodolac—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.00022	0.00441	CbGpPWpGaD
Etodolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000218	0.00437	CbGpPWpGaD
Etodolac—PTGS1—endocrine gland—brain cancer	0.000218	0.00984	CbGeAlD
Etodolac—Paraesthesia—Etoposide—brain cancer	0.000216	0.00124	CcSEcCtD
Etodolac—Asthenia—Temozolomide—brain cancer	0.000216	0.00124	CcSEcCtD
Etodolac—PTGS1—head—brain cancer	0.000215	0.00972	CbGeAlD
Etodolac—Dyspnoea—Etoposide—brain cancer	0.000215	0.00123	CcSEcCtD
Etodolac—Somnolence—Etoposide—brain cancer	0.000214	0.00123	CcSEcCtD
Etodolac—Diarrhoea—Carmustine—brain cancer	0.000213	0.00122	CcSEcCtD
Etodolac—Pruritus—Temozolomide—brain cancer	0.000213	0.00122	CcSEcCtD
Etodolac—UGT1A9—PPAR Alpha Pathway—MYC—brain cancer	0.00021	0.00422	CbGpPWpGaD
Etodolac—Decreased appetite—Etoposide—brain cancer	0.000209	0.0012	CcSEcCtD
Etodolac—PTGS2—endocrine gland—brain cancer	0.000208	0.00941	CbGeAlD
Etodolac—Fatigue—Etoposide—brain cancer	0.000207	0.00119	CcSEcCtD
Etodolac—Dizziness—Carmustine—brain cancer	0.000206	0.00118	CcSEcCtD
Etodolac—Constipation—Etoposide—brain cancer	0.000206	0.00118	CcSEcCtD
Etodolac—Pain—Etoposide—brain cancer	0.000206	0.00118	CcSEcCtD
Etodolac—Diarrhoea—Temozolomide—brain cancer	0.000206	0.00118	CcSEcCtD
Etodolac—PTGS2—head—brain cancer	0.000205	0.00929	CbGeAlD
Etodolac—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.000203	0.00408	CbGpPWpGaD
Etodolac—Dizziness—Temozolomide—brain cancer	0.000199	0.00114	CcSEcCtD
Etodolac—Feeling abnormal—Etoposide—brain cancer	0.000198	0.00114	CcSEcCtD
Etodolac—Vomiting—Carmustine—brain cancer	0.000198	0.00114	CcSEcCtD
Etodolac—Gastrointestinal pain—Etoposide—brain cancer	0.000197	0.00113	CcSEcCtD
Etodolac—Rash—Carmustine—brain cancer	0.000196	0.00113	CcSEcCtD
Etodolac—PTGS1—central nervous system—brain cancer	0.000196	0.00887	CbGeAlD
Etodolac—Dermatitis—Carmustine—brain cancer	0.000196	0.00113	CcSEcCtD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—brain cancer	0.000196	0.00392	CbGpPWpGaD
Etodolac—Headache—Carmustine—brain cancer	0.000195	0.00112	CcSEcCtD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000194	0.00389	CbGpPWpGaD
Etodolac—Vomiting—Temozolomide—brain cancer	0.000191	0.0011	CcSEcCtD
Etodolac—Urticaria—Etoposide—brain cancer	0.000191	0.0011	CcSEcCtD
Etodolac—Abdominal pain—Etoposide—brain cancer	0.00019	0.00109	CcSEcCtD
Etodolac—Body temperature increased—Etoposide—brain cancer	0.00019	0.00109	CcSEcCtD
Etodolac—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.00019	0.00381	CbGpPWpGaD
Etodolac—Rash—Temozolomide—brain cancer	0.00019	0.00109	CcSEcCtD
Etodolac—Dermatitis—Temozolomide—brain cancer	0.000189	0.00109	CcSEcCtD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000189	0.00378	CbGpPWpGaD
Etodolac—Headache—Temozolomide—brain cancer	0.000188	0.00108	CcSEcCtD
Etodolac—PTGS2—central nervous system—brain cancer	0.000188	0.00848	CbGeAlD
Etodolac—Nausea—Carmustine—brain cancer	0.000185	0.00106	CcSEcCtD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000184	0.00369	CbGpPWpGaD
Etodolac—PTGS2—cerebellum—brain cancer	0.000183	0.00829	CbGeAlD
Etodolac—Nausea—Temozolomide—brain cancer	0.000179	0.00103	CcSEcCtD
Etodolac—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.000178	0.00358	CbGpPWpGaD
Etodolac—Hypersensitivity—Etoposide—brain cancer	0.000177	0.00102	CcSEcCtD
Etodolac—Asthenia—Etoposide—brain cancer	0.000173	0.000993	CcSEcCtD
Etodolac—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000172	0.00344	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.00017	0.00342	CbGpPWpGaD
Etodolac—Pruritus—Etoposide—brain cancer	0.00017	0.000979	CcSEcCtD
Etodolac—Diarrhoea—Etoposide—brain cancer	0.000165	0.000947	CcSEcCtD
Etodolac—RXRA—Transmembrane transport of small molecules—S100A10—brain cancer	0.000161	0.00323	CbGpPWpGaD
Etodolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	0.00016	0.0032	CbGpPWpGaD
Etodolac—Dizziness—Etoposide—brain cancer	0.000159	0.000915	CcSEcCtD
Etodolac—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000159	0.00319	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000158	0.00316	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000156	0.00312	CbGpPWpGaD
Etodolac—PTGS1—brain—brain cancer	0.000156	0.00704	CbGeAlD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000155	0.00311	CbGpPWpGaD
Etodolac—Vomiting—Etoposide—brain cancer	0.000153	0.00088	CcSEcCtD
Etodolac—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	0.000152	0.00305	CbGpPWpGaD
Etodolac—Rash—Etoposide—brain cancer	0.000152	0.000872	CcSEcCtD
Etodolac—Dermatitis—Etoposide—brain cancer	0.000152	0.000872	CcSEcCtD
Etodolac—Headache—Etoposide—brain cancer	0.000151	0.000867	CcSEcCtD
Etodolac—PTGS2—brain—brain cancer	0.000149	0.00673	CbGeAlD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—brain cancer	0.000144	0.00288	CbGpPWpGaD
Etodolac—Nausea—Etoposide—brain cancer	0.000143	0.000822	CcSEcCtD
Etodolac—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000141	0.00283	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00014	0.00281	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—IRS2—brain cancer	0.000137	0.00275	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—HES1—brain cancer	0.000131	0.00263	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.00013	0.00261	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—SOD2—brain cancer	0.000128	0.00257	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000128	0.00256	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	0.000126	0.00253	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000125	0.00251	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000124	0.00248	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000122	0.00246	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000122	0.00245	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000115	0.0023	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000109	0.00219	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000109	0.00219	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000104	0.00208	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	0.000103	0.00207	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000103	0.00206	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.000102	0.00205	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.96e-05	0.002	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	9.46e-05	0.0019	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	9.38e-05	0.00188	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	9.18e-05	0.00184	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—RELA—brain cancer	9.13e-05	0.00183	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.93e-05	0.00179	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	8.9e-05	0.00178	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MPL—brain cancer	8.84e-05	0.00177	CbGpPWpGaD
Etodolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	8.82e-05	0.00177	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	8.76e-05	0.00175	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TRPC6—brain cancer	8.75e-05	0.00175	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	8.63e-05	0.00173	CbGpPWpGaD
Etodolac—ALB—Hemostasis—S100A10—brain cancer	8.48e-05	0.0017	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	8.44e-05	0.00169	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—CTNNB1—brain cancer	8.23e-05	0.00165	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.91e-05	0.00158	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP2C9—brain cancer	7.87e-05	0.00158	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	7.86e-05	0.00158	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—CDK4—brain cancer	7.84e-05	0.00157	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—ESR2—brain cancer	7.71e-05	0.00155	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	7.6e-05	0.00152	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—TRPC6—brain cancer	7.43e-05	0.00149	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—RELA—brain cancer	7.42e-05	0.00149	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	7.34e-05	0.00147	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—NOTCH2—brain cancer	7.31e-05	0.00146	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	7.29e-05	0.00146	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.28e-05	0.00146	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	7.19e-05	0.00144	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—STAT3—brain cancer	7.17e-05	0.00144	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	7.05e-05	0.00141	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	6.96e-05	0.0014	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	6.91e-05	0.00139	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—BSG—brain cancer	6.69e-05	0.00134	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP2C9—brain cancer	6.69e-05	0.00134	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL2—brain cancer	6.69e-05	0.00134	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	6.64e-05	0.00133	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	6.52e-05	0.00131	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	6.47e-05	0.0013	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.4e-05	0.00128	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP2C9—brain cancer	6.24e-05	0.00125	CbGpPWpGaD
Etodolac—PTGS2—Disease—DTX2—brain cancer	6.22e-05	0.00125	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	6.17e-05	0.00124	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.11e-05	0.00122	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.05e-05	0.00121	CbGpPWpGaD
Etodolac—ALB—Hemostasis—BSG—brain cancer	5.97e-05	0.0012	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—RELA—brain cancer	5.9e-05	0.00118	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.78e-05	0.00116	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—IDH1—brain cancer	5.76e-05	0.00115	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—BSG—brain cancer	5.69e-05	0.00114	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	5.69e-05	0.00114	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—HES1—brain cancer	5.64e-05	0.00113	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP2C9—brain cancer	5.44e-05	0.00109	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	5.33e-05	0.00107	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—MYC—brain cancer	5.33e-05	0.00107	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.32e-05	0.00107	CbGpPWpGaD
Etodolac—RXRA—Metabolism—BSG—brain cancer	5.31e-05	0.00106	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL2—brain cancer	5.19e-05	0.00104	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—CCND1—brain cancer	5.06e-05	0.00101	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	5.02e-05	0.00101	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.9e-05	0.000982	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—IDH1—brain cancer	4.9e-05	0.000981	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—VEGFA—brain cancer	4.87e-05	0.000977	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.79e-05	0.000961	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.68e-05	0.000937	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	4.64e-05	0.00093	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—BSG—brain cancer	4.63e-05	0.000927	CbGpPWpGaD
Etodolac—PTGS2—Disease—HES5—brain cancer	4.57e-05	0.000916	CbGpPWpGaD
Etodolac—RXRA—Metabolism—IDH1—brain cancer	4.57e-05	0.000915	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ENO2—brain cancer	4.55e-05	0.000912	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP2C9—brain cancer	4.43e-05	0.000889	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—CDK4—brain cancer	4.42e-05	0.000886	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TP53—brain cancer	4.29e-05	0.000861	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—DNMT1—brain cancer	4.14e-05	0.000829	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MYC—brain cancer	4.06e-05	0.000814	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.02e-05	0.000806	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—IDH1—brain cancer	3.98e-05	0.000797	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—EGFR—brain cancer	3.97e-05	0.000796	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TRPC6—brain cancer	3.92e-05	0.000785	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.9e-05	0.000781	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ENO2—brain cancer	3.87e-05	0.000776	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.83e-05	0.000767	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—BSG—brain cancer	3.77e-05	0.000756	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.72e-05	0.000745	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—ESR2—brain cancer	3.71e-05	0.000745	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	3.61e-05	0.000724	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ENO2—brain cancer	3.61e-05	0.000724	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP2C9—brain cancer	3.52e-05	0.000706	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—NOTCH2—brain cancer	3.52e-05	0.000705	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.44e-05	0.00069	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.41e-05	0.000684	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	3.39e-05	0.000679	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TP53—brain cancer	3.33e-05	0.000668	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—RELA—brain cancer	3.25e-05	0.000652	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—IDH1—brain cancer	3.24e-05	0.00065	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.24e-05	0.000649	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—ERBB2—brain cancer	3.23e-05	0.000648	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ENO2—brain cancer	3.14e-05	0.00063	CbGpPWpGaD
Etodolac—PTGS2—Disease—IDH1—brain cancer	3.07e-05	0.000616	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3e-05	0.000602	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—BSG—brain cancer	2.99e-05	0.0006	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SIRT1—brain cancer	2.99e-05	0.0006	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VAV1—brain cancer	2.93e-05	0.000588	CbGpPWpGaD
Etodolac—PTGS2—Disease—HEY1—brain cancer	2.91e-05	0.000584	CbGpPWpGaD
Etodolac—PTGS2—Disease—DLL1—brain cancer	2.86e-05	0.000573	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP2C9—brain cancer	2.85e-05	0.000571	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—CTNNB1—brain cancer	2.83e-05	0.000567	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.76e-05	0.000554	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.7e-05	0.000542	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.64e-05	0.000529	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—IDH1—brain cancer	2.57e-05	0.000516	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ENO2—brain cancer	2.56e-05	0.000514	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	2.54e-05	0.00051	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—brain cancer	2.49e-05	0.000499	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—STAT3—brain cancer	2.47e-05	0.000494	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—MYC—brain cancer	2.43e-05	0.000488	CbGpPWpGaD
Etodolac—PTGS2—Disease—SHH—brain cancer	2.43e-05	0.000487	CbGpPWpGaD
Etodolac—PTGS2—Disease—ENO2—brain cancer	2.43e-05	0.000487	CbGpPWpGaD
Etodolac—ALB—Metabolism—BSG—brain cancer	2.42e-05	0.000485	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.27e-05	0.000455	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—EGFR—brain cancer	2.24e-05	0.000449	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.16e-05	0.000433	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.1e-05	0.00042	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CG—brain cancer	2.09e-05	0.000418	CbGpPWpGaD
Etodolac—ALB—Metabolism—IDH1—brain cancer	2.08e-05	0.000417	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ENO2—brain cancer	2.03e-05	0.000408	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—BSG—brain cancer	1.98e-05	0.000397	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CG—brain cancer	1.86e-05	0.000373	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CG—brain cancer	1.78e-05	0.000356	CbGpPWpGaD
Etodolac—PTGS2—Disease—VAV1—brain cancer	1.76e-05	0.000352	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—IDH1—brain cancer	1.7e-05	0.000342	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.7e-05	0.00034	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CG—brain cancer	1.66e-05	0.000332	CbGpPWpGaD
Etodolac—ALB—Metabolism—ENO2—brain cancer	1.65e-05	0.00033	CbGpPWpGaD
Etodolac—PTGS2—Disease—HES1—brain cancer	1.51e-05	0.000303	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CG—brain cancer	1.44e-05	0.000289	CbGpPWpGaD
Etodolac—PTGS2—Disease—PDGFRA—brain cancer	1.44e-05	0.000288	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.39e-05	0.000278	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ENO2—brain cancer	1.35e-05	0.00027	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2—brain cancer	1.31e-05	0.000263	CbGpPWpGaD
Etodolac—PTGS2—Disease—IRS2—brain cancer	1.26e-05	0.000253	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CG—brain cancer	1.18e-05	0.000236	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—brain cancer	1.17e-05	0.000235	CbGpPWpGaD
Etodolac—PTGS2—Disease—APC—brain cancer	1.11e-05	0.000223	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—brain cancer	1.11e-05	0.000223	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CG—brain cancer	9.33e-06	0.000187	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB2—brain cancer	8.65e-06	0.000173	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—brain cancer	8.42e-06	0.000169	CbGpPWpGaD
Etodolac—PTGS2—Disease—CTNNB1—brain cancer	7.57e-06	0.000152	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CG—brain cancer	7.55e-06	0.000151	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—brain cancer	6.6e-06	0.000132	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CG—brain cancer	6.18e-06	0.000124	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—brain cancer	6.13e-06	0.000123	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGFR—brain cancer	6e-06	0.00012	CbGpPWpGaD
